Who owns the ASHERBIO trademark?

The ASHERBIO trademark is owned by Asher Biotherapeutics, Inc..

What is the serial number for ASHERBIO?

The USPTO serial number for ASHERBIO is 90694701.

What is the registration number for ASHERBIO?

ASHERBIO is registered under USPTO registration number 7062914.

ASH

USPTO Trademark Record

REGISTERED

ASHERBIO

Q: What class is the ASHERBIO trademark registered in?

The ASHERBIO trademark is registered in Class 005 (Pharmaceuticals, medical & veterinary preparations), Class 042 (Scientific, technology & SaaS services).

SN 90694701·Reg 7062914·Filed May 06, 2021

Owner Asher Biotherapeutics, Inc.

Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary purposes, food for babies; dietary supplements for human beings and animals; adhesive plasters, materials for dressings; material for filling teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.; Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.

ASHERBIO (Serial No. 90694701), Registration No. 7062914, is a registered US trademark filed on May 06, 2021 by Asher Biotherapeutics, Inc.. This trademark covers Class 005 (Pharmaceuticals, medical & veterinary preparations), Class 042 (Scientific, technology & SaaS services).

early section 8: May 23, 2029

Mark Intelligence

ASHERBIO (Reg. #7062914) is a registered US trademark that has been protecting its owner, Asher Biotherapeutics, Inc., since 2021. The mark covers Class 005 (Pharmaceuticals, medical & veterinary preparations) and Class 042 (Scientific, technology & SaaS services) respectively. Goods and services include Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and subs.... The mark faced 1 opposition proceeding during prosecution.

FILED

May 06, 2021

SERIAL

90694701

REG#

7062914

REGISTERED

May 23, 2023

Owner

Applicant

Asher Biotherapeutics, Inc.

Entity

Corporation

State

Address

650 Gateway Blvd., South San Francisco, CA, 94080

Country

Attorney

NameJoyce Liou

Law firm

Joyce Liou MORRISON & FOERSTER LLP

Docket

182846002000

Address

425 MARKET STREET, SAN FRANCISCO, CA 94105, UNITED STATES

Get pre-filing clearance

AI attorney analyzes your proposed mark against USPTO — Go/No-Go verdict, class-by-class risks, and strategy recommendations.

Run clearance

Filing Information

StatusREGISTERED

Filing DateMay 06, 2021

Serial Number90694701

Registration No.7062914

Registration DateMay 23, 2023

Status DateMay 23, 2023

Published for OppositionFeb 15, 2022

Mark TypeStylized characters

Attorney Docket182846002000

Status DescriptionLive and registered

Filing Signals

FILED

2021

YEARS AGO

CLASSES

MADRID FILINGS

Opposed 1× during prosecution

Search 14M+ trademarks

Free USPTO lookups by name, owner, or serial number. No account needed.

Search now

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 005Pharmaceuticals, medical & veterinary preparations

US codes: 005, 006, 018, 044, 046, 051, 052

First use anywhere: Sep 23, 2022

First use in commerce: Sep 23, 2022

Class 042Scientific, technology & SaaS services

US codes: 100, 101

First use anywhere: Sep 23, 2022

First use in commerce: Sep 23, 2022

Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.

This description is as filed with the USPTO and defines the scope of trademark protection.

Status History

24 events

REGISTERED-PRINCIPAL REGISTER

May 23, 2023

REGISTERED-PRINCIPAL REGISTER

NOTICE OF REGISTRATION CONFIRMATION EMAILED

May 23, 2023

NOTICE OF REGISTRATION CONFIRMATION EMAILED

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

Apr 18, 2023

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Apr 18, 2023

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

CASE ASSIGNED TO INTENT TO USE PARALEGAL

Apr 17, 2023

CASE ASSIGNED TO INTENT TO USE PARALEGAL

SOU EXTENSION 2 GRANTED

Apr 17, 2023

SOU EXTENSION 2 GRANTED

STATEMENT OF USE PROCESSING COMPLETE

Apr 17, 2023

STATEMENT OF USE PROCESSING COMPLETE

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

Apr 17, 2023

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

TEAS STATEMENT OF USE RECEIVED

Apr 11, 2023

TEAS STATEMENT OF USE RECEIVED

SOU TEAS EXTENSION RECEIVED

Apr 11, 2023

SOU TEAS EXTENSION RECEIVED

SOU EXTENSION 2 FILED

Apr 11, 2023

SOU EXTENSION 2 FILED

USE AMENDMENT FILED

Apr 11, 2023

USE AMENDMENT FILED

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Oct 14, 2022

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

SOU TEAS EXTENSION RECEIVED

Oct 12, 2022

SOU TEAS EXTENSION RECEIVED

SOU EXTENSION 1 FILED

Oct 12, 2022

SOU EXTENSION 1 FILED

SOU EXTENSION 1 GRANTED

Oct 12, 2022

SOU EXTENSION 1 GRANTED

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Apr 12, 2022

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

PUBLISHED FOR OPPOSITION

Feb 15, 2022

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Feb 15, 2022

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Jan 26, 2022

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

APPROVED FOR PUB - PRINCIPAL REGISTER

Jan 12, 2022

APPROVED FOR PUB - PRINCIPAL REGISTER

ASSIGNED TO EXAMINER

Jan 10, 2022

ASSIGNED TO EXAMINER

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Aug 10, 2021

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

NEW APPLICATION ENTERED

May 10, 2021

NEW APPLICATION ENTERED

ASHERBIO

Get pre-filing clearance

Search 14M+ trademarks

Run a conflict check

Other Marks by Asher Biotherapeutics, Inc.

Other Marks by Joyce Liou

Resources

Company